CRCHD Scholars Demonstrate Breadth of Cancer Research in Professional Development Workshop Flash Talks
, by CRCHD Staff
More than 120 scholars attended the 2019 Professional Development Workshop (PDW) and Mock Review (MR), which was hosted by the National Cancer Institute’s (NCI) Center to Reduce Cancer Health Disparities (CRCHD) on June 3-4, 2019, at the NIH Natcher Conference Center. The theme of this year’s workshop was “Training 21st Century Leaders,” including addressing where the science is headed, tools that may be necessary to keep pace, and what career opportunities are available.
One of the highlights at the annual PDW & MR is the opportunity for scholars to present flash talks, which are followed by poster visits. This year, flash talks were delivered by scholars from each of the three CRCHD programs represented at the conference—Continuing Umbrella of Research Experiences (CURE), Intramural Continuing Umbrella of Research Experiences (iCURE), and Partnerships to Advance Cancer Health Equity (PACHE).
Through these flash talks, CRCHD allows time for attendees to share their science and build connections with fellow scholars, other attendees and NCI program staff. Certain flash talk presenters are included in this blog post to demonstrate the breadth of research presented across research types and across CRCHD programs.
Suhn Rhie, PhD, CURE Scholar, K01
University of Southern California Keck School of Medicine
Intratumoral Heterogeneity and Immune Checkpoint Inhibitor Response in the KPC Pancreatic Cancer Model.
Sarah Martinez Roth, MS, CURE Scholar, F31
Characterization of the Immune Response to Lymph Node Metastases.
Dennis Jones, PhD, CURE Scholar, K22
Boston University School of Medicine
SVCurator: A Crowdsourcing App to Visualize Evidence of Structural Variants for the Human Genome.
Lesley Chapman, PhD, iCURE Postdoctoral Scholar
National Cancer Institute
STAT1 Mediates Resistance to Oral Tumor Development in an Experimental Model of Oral Carcinogenesis.
Steve Oghumu, PhD, CURE Scholar, K01
The Ohio State University
Expression and Clinical Significance of Adipokines and Adipokine Receptors in Breast Cancer.
Adana Llanos, PhD, MPH, CURE Scholar, K01
Rutgers School of Public Health/Rutgers Cancer Institute of New Jersey
KDM5B Mediates Cell Survival in MYC-Dependent T-ALL.
Daniel Liefwalker, PhD, CURE Scholar, K01
Oregon Health and Science University
New DNA Repair Alterations in Hereditary Cancer Development.
Rosa Munoz Xicola, PhD, CURE Scholar, K01
Yale School of Medicine/Yale Cancer Center
Association of a Novel Chemokine, CXCL14, in TNBC Tumor Microenvironment Remodeling.
Carla Gibbs, BS, iCURE Graduate Student Scholar
Meharry Medical College/National Cancer Institute
Endometrial Carcinoma Recurrence According to Race and Ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.
Ashley Felix, PhD, MPH, CURE Scholar, K01
The Ohio State University College of Public Health
Common Childhood Viruses and Pubertal Timing: The LEGACY Girls Study.
Jasmine McDonald, PhD, CURE Scholar, K01
Mailman School of Public Health/Columbia University Medical Center
Empowering Latinas to Obtain Breast Cancer Screenings: Comparing Intervention Effects and Cost-Effectiveness.
Yamilé Molina, PhD, MPH, CURE Scholar, K01
University of Illinois at Chicago
When Engagement Leads to Action: Understanding the Impact of Cancer (Mis)information among Latino Facebook Users.
Yonaira Rivera, MPH, CURE Scholar, F31
Johns Hopkins Bloomberg School of Public Health
Social Constraints and Insomnia in African-American Breast Cancer Survivors: The Moderating Role of Emotional Intelligence.
Chloe Martin, PhD, Postdoctoral Scholar (T32)
Memorial Sloan Kettering Cancer Center
For more information about CURE, iCURE and PACHE, please visit the CRCHD website.